Bristol-Myers Squibb
BMY
#164
Rank
C$164.19 B
Marketcap
C$80.63
Share price
-1.08%
Change (1 day)
-3.60%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): C$4.17

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is C$4.08. In 2024 the company made an earnings per share (EPS) of C-$6.07 a decrease over its 2023 EPS that were of C$5.33.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$4.17-168.77%
2024C-$6.07-213.92%
2023C$5.3330.2%
2022C$4.09-6.04%
2021C$4.35-179.29%
2020C-$5.49-281.37%
2019C$3.03-27.21%
2018C$4.16
2016C$3.67175.26%
2015C$1.33-19.83%
2014C$1.66-22.44%
2013C$2.1434.48%
2012C$1.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$15.29 275.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$10.10 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.87-54.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$3.28-19.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.60 675.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$19.67 382.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.84-30.47%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$15.09 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.03 146.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$7.34 80.13%๐Ÿ‡ฌ๐Ÿ‡ง UK